Elizete Aparecida Lomazi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elizete Aparecida Lomazi has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Maria Angela Bellomo-Brandão
Universidade Estadual de Campinas, Brazil
17 shared publications - José Dirceu Ribeiro
Department of Pediatrics, State University of Campinas, Campinas, Brazil
12 shared publications - Natascha Silva Sandy
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
11 shared publications - Maria de Fatima Servidoni
Universidade Estadual de Campinas, Brasil
9 shared publications - Antonio Fernando Ribeiro
Universidade Estadual de Campinas (UNICAMP), Faculdade de Ciências Médicas (FCM), Department of Pediatrics, Campinas, SP, Brazil
8 shared publications - Adriana Gut Lopes Riccetto
Univ Estadual Campinas Unicamp, Fac Ciencias Med, Dept Pediat, Campinas, SP, Brazil
4 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by Elsevier in Jornal de Pediatria
- Vol. 102 (5)
Isolated rectal bleeding in neonates: a scoping review
- 12 August 2026
- Published by Elsevier in Jornal de Pediatria
- Vol. 102 (5)
Open AccessIsolated rectal bleeding in neonates: a scoping review
- Open Access
- 9 May 2026
- Published by Elsevier in Jornal de Pediatria
- Vol. 102 (4) , 101552
Assessment of abdominal symptoms and intestinal inflammation in children and adolescents with cystic fibrosis without highly effective modulator therapy
- 9 May 2026
- Published by Elsevier in Jornal de Pediatria
- Vol. 102 (4) , 101552
Open AccessAssessment of abdominal symptoms and intestinal inflammation in children and adolescents with cystic fibrosis without highly effective modulator therapy
- 16 April 2026
- Published by Elsevier in Journal of Pediatric Health Care
- Vol. 40 (5) , e231-e236
Telehealth - A Clinical Practice Initiative in Pediatrics
- 16 April 2026
- Published by Elsevier in Journal of Pediatric Health Care
- Vol. 40 (5) , e231-e236
Telehealth - A Clinical Practice Initiative in Pediatrics
- Open Access
- 26 March 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 83 (1) , 87-95
Upper and small bowel Crohn's disease in Brazilian children: Phenotypic characteristic and surgical risk
Objectives: Upper and small bowel Crohn's disease (U‐SBCD) represents a clinically aggressive phenotype with high complication rates yet remains diagnostically challenging. In low‐ and middle‐income countries (LMICs), limited inflammatory bowel disease (IBD) awareness contributes to diagnostic delays, but their impact on U‐SBCD outcomes remains poorly characterized. We aimed to characterize clinical features, management patterns, and surgical outcomes of pediatric U‐SBCD in Brazil, establishing IBD baseline for future regional comparisons in LMIC setting. Methods: This multicenter retrospective study analyzed 124 pediatric Crohn′s disease (CD) patients (diagnosed < 18 years) from six Brazilian centers according to revised PORTO‐European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) criteria. Patients with U‐SBCD (Paris L4a/L4b, n = 39) were compared to non‐SBCD (L1/L2/L3). Univariate and multivariable analyses assessed demographics, diagnostic delay, disease behavior, growth impairment, and therapeutic outcomes over 18 months follow‐up. The population comprised predominantly African–Brazilian admixture. Results: U‐SBCD patients presented at older age (median 14 vs. 12 years; p = 0.001) with greater height impairment ( p = 0.010) and lower body mass index (BMI)/age z ‐scores (−1.14 vs. −0.44; p = 0.029). Severe weight loss ( z ‐score < −2) conferred 8.3‐fold increased U‐SBCD odds (95% confidence interval [CI]: 2.17–31.66; p = 0.002). Each year of diagnostic delay increased U‐SBCD odds by 22% (95% CI: 1.06–1.39; p = 0.004). U‐SBCD patients required more biologic therapy (97% vs. 75%; p = 0.003) with higher treatment escalation rates (31.6% vs. 21.2%; p = 0.004). Multivariate analysis confirmed U‐SBCD as an independent three‐fold predictor of surgery (OR 3.02; 95% CI: 1.02–8.94; p = 0.046). A 9‐year‐old girl with U‐SBCD died perioperatively. Psychiatric symptoms affected 30% of both groups. Conclusion: In LMIC settings, strengthening medical education is essential to improve early recognition of U‐SBCD and prevent progression to irreversible complications. Notably, the phenotypic pattern observed in our study more closely resembled that reported in Asian pediatric patients than Caucasian cohorts.
- 26 March 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 83 (1) , 87-95
Open AccessUpper and small bowel Crohn's disease in Brazilian children: Phenotypic characteristic and surgical risk
Objectives: Upper and small bowel Crohn's disease (U‐SBCD) represents a clinically aggressive phenotype with high complication rates yet remains diagnostically challenging. In low‐ and middle‐income countries (LMICs), limited inflammatory bowel disease (IBD) awareness contributes to diagnostic delays, but their impact on U‐SBCD outcomes remains poorly characterized. We aimed to characterize clinical features, management patterns, and surgical outcomes of pediatric U‐SBCD in Brazil, establishing IBD baseline for future regional comparisons in LMIC setting. Methods: This multicenter retrospective study analyzed 124 pediatric Crohn′s disease (CD) patients (diagnosed < 18 years) from six Brazilian centers according to revised PORTO‐European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) criteria. Patients with U‐SBCD (Paris L4a/L4b, n = 39) were compared to non‐SBCD (L1/L2/L3). Univariate and multivariable analyses assessed demographics, diagnostic delay, disease behavior, growth impairment, and therapeutic outcomes over 18 months follow‐up. The population comprised predominantly African–Brazilian admixture. Results: U‐SBCD patients presented at older age (median 14 vs. 12 years; p = 0.001) with greater height impairment ( p = 0.010) and lower body mass index (BMI)/age z ‐scores (−1.14 vs. −0.44; p = 0.029). Severe weight loss ( z ‐score < −2) conferred 8.3‐fold increased U‐SBCD odds (95% confidence interval [CI]: 2.17–31.66; p = 0.002). Each year of diagnostic delay increased U‐SBCD odds by 22% (95% CI: 1.06–1.39; p = 0.004). U‐SBCD patients required more biologic therapy (97% vs. 75%; p = 0.003) with higher treatment escalation rates (31.6% vs. 21.2%; p = 0.004). Multivariate analysis confirmed U‐SBCD as an independent three‐fold predictor of surgery (OR 3.02; 95% CI: 1.02–8.94; p = 0.046). A 9‐year‐old girl with U‐SBCD died perioperatively. Psychiatric symptoms affected 30% of both groups. Conclusion: In LMIC settings, strengthening medical education is essential to improve early recognition of U‐SBCD and prevent progression to irreversible complications. Notably, the phenotypic pattern observed in our study more closely resembled that reported in Asian pediatric patients than Caucasian cohorts.
- Open Access
- 18 January 2026
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 38
Cow's milk protein-induced FPIES: Clinical outcomes in severe cases
- 18 January 2026
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 38
Open AccessCow's milk protein-induced FPIES: Clinical outcomes in severe cases
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 63, e26037
SEVERE COMPLICATIONS OF BUTTON BATTERY INGESTION IN CHILDREN
Background: Button battery (BB) ingestion has emerged as a global health concern, particularly among children. Objective: To investigate the clinical outcomes and complications related to BB ingestion among pediatric patients managed at a referral center. Methods: A case series study was conducted between March 2016 and December 2023, including patients under 14 years old diagnosed with BB ingestion. Clinical and radiological evaluations were performed, followed by endoscopic assessment and treatment when required. Data collected included clinical presentation, endoscopic findings, complications, and outcomes. Results: A total of 568 cases of foreign body ingestion were initially reviewed, from which only 16 pediatric patients with confirmed BB ingestion were identified between 2016 and 2023. No cases were documented between 2016 and 2018; however, a substantial increase was observed from 2019 through 2022, with a pronounced surge during 2020-2021 that coincided with the COVID-19 pandemic (P=0.011). Patient ages ranged from 3 months to 5 years, with a median of 3.22 years (1.62-4.55). Endoscopic retrieval was required in seven children (n=7, 43.7%), whereas nine did not undergo endoscopic intervention owing to the extraesophageal location of the BB. Complications were documented in seven patients, including ulceration (n=6; 37.5%), fistulas (n=3, 18.7%), and stenosis (n=3, 18.7%). Conclusion: This study highlights the significant risks of severe complications associated with BB ingestion, even in very young children. A significant increase in severe cases referred to our center during the COVID-19 pandemic underscores the importance of awareness, prevention, and timely medical intervention.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 63, e26037
Open AccessSEVERE COMPLICATIONS OF BUTTON BATTERY INGESTION IN CHILDREN
Background: Button battery (BB) ingestion has emerged as a global health concern, particularly among children. Objective: To investigate the clinical outcomes and complications related to BB ingestion among pediatric patients managed at a referral center. Methods: A case series study was conducted between March 2016 and December 2023, including patients under 14 years old diagnosed with BB ingestion. Clinical and radiological evaluations were performed, followed by endoscopic assessment and treatment when required. Data collected included clinical presentation, endoscopic findings, complications, and outcomes. Results: A total of 568 cases of foreign body ingestion were initially reviewed, from which only 16 pediatric patients with confirmed BB ingestion were identified between 2016 and 2023. No cases were documented between 2016 and 2018; however, a substantial increase was observed from 2019 through 2022, with a pronounced surge during 2020-2021 that coincided with the COVID-19 pandemic (P=0.011). Patient ages ranged from 3 months to 5 years, with a median of 3.22 years (1.62-4.55). Endoscopic retrieval was required in seven children (n=7, 43.7%), whereas nine did not undergo endoscopic intervention owing to the extraesophageal location of the BB. Complications were documented in seven patients, including ulceration (n=6; 37.5%), fistulas (n=3, 18.7%), and stenosis (n=3, 18.7%). Conclusion: This study highlights the significant risks of severe complications associated with BB ingestion, even in very young children. A significant increase in severe cases referred to our center during the COVID-19 pandemic underscores the importance of awareness, prevention, and timely medical intervention.
- Open Access
- 23 December 2025
- Published by Elsevier in Jornal de Pediatria
- Vol. 102 (1) , 101488
Diet quality in Brazilian adolescents with cystic fibrosis
- 23 December 2025
- Published by Elsevier in Jornal de Pediatria
- Vol. 102 (1) , 101488
Open AccessDiet quality in Brazilian adolescents with cystic fibrosis
- Open Access
- 15 April 2025
- Published by MDPI AG in Preprints.org
Food Protein-Induced Enterocolitis Syndrome (FPIES): Clinical Outcomes
Background/Objectives: Food Protein-Induced Enterocolitis Syndrome (FPIES) is a rare and poorly understood condition that primarily affects infants and young children. This study aimed to evaluate the clinical characteristics and outcomes of oral food challenge (OFC) tests in patients diagnosed with FPIES. Methods: A retrospective cohort study was conducted on pediatric patients who underwent OFCs for FPIES at a tertiary health service from January 16, 2018, to June 20, 2024. Both accidental and scheduled in-hospital OFC results were considered. Results: Five patients were included, and 19 OFCs were evaluated. Four patients underwent 4 OFCs each, and one patient underwent 3 OFCs. The mean age of the first symptom onset was 35 days (ranging from 3 days to 2 months). Before the first OFC, the mean duration of the elimination diet was 7 months, and for patients who required additional OFCs, was 11.6 months. Four patients were admitted to the intensive care unit. Two patients were being fed on formula, and three were having mixed feeding. Two patients had a personal and family history of atopy, and one had only a family history of atopy. Two patients had genetic syndromes. All patients developed tolerance to cow’s milk protein within a mean time of 44 months, ranging from 17 to 103 months. The two patients with genetic syndromes had a longer time to develop tolerance. Conclusions: FPIES may require multiple OFCs for diagnosis and management. The time to develop tolerance was longer in patients with genetic syndromes.
- 15 April 2025
- Published by MDPI AG in Preprints.org
Open AccessFood Protein-Induced Enterocolitis Syndrome (FPIES): Clinical Outcomes
Background/Objectives: Food Protein-Induced Enterocolitis Syndrome (FPIES) is a rare and poorly understood condition that primarily affects infants and young children. This study aimed to evaluate the clinical characteristics and outcomes of oral food challenge (OFC) tests in patients diagnosed with FPIES. Methods: A retrospective cohort study was conducted on pediatric patients who underwent OFCs for FPIES at a tertiary health service from January 16, 2018, to June 20, 2024. Both accidental and scheduled in-hospital OFC results were considered. Results: Five patients were included, and 19 OFCs were evaluated. Four patients underwent 4 OFCs each, and one patient underwent 3 OFCs. The mean age of the first symptom onset was 35 days (ranging from 3 days to 2 months). Before the first OFC, the mean duration of the elimination diet was 7 months, and for patients who required additional OFCs, was 11.6 months. Four patients were admitted to the intensive care unit. Two patients were being fed on formula, and three were having mixed feeding. Two patients had a personal and family history of atopy, and one had only a family history of atopy. Two patients had genetic syndromes. All patients developed tolerance to cow’s milk protein within a mean time of 44 months, ranging from 17 to 103 months. The two patients with genetic syndromes had a longer time to develop tolerance. Conclusions: FPIES may require multiple OFCs for diagnosis and management. The time to develop tolerance was longer in patients with genetic syndromes.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 62, e24110
SMALL INTESTINAL BACTERIAL OVERGROWTH IN PEOPLE WITH CYSTIC FIBROSIS: SYSTEMATIC REVIEW
Background: In patients with cystic fibrosis (pwCF) acid suppression therapy, gastrointestinal dysmotility, and post-operative bowel status, may predispose to the development of small intestinal bacterial overgrowth (SIBO). SIBO may continue to be present in the progression of the disease even on modulators. Breath testing is the most simple, non-invasive and available method for diagnosing SIBO. There are some divergencies over the operational procedures used to carry out and interpret breath tests in pwCF.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 62, e24110
Open AccessSMALL INTESTINAL BACTERIAL OVERGROWTH IN PEOPLE WITH CYSTIC FIBROSIS: SYSTEMATIC REVIEW
Background: In patients with cystic fibrosis (pwCF) acid suppression therapy, gastrointestinal dysmotility, and post-operative bowel status, may predispose to the development of small intestinal bacterial overgrowth (SIBO). SIBO may continue to be present in the progression of the disease even on modulators. Breath testing is the most simple, non-invasive and available method for diagnosing SIBO. There are some divergencies over the operational procedures used to carry out and interpret breath tests in pwCF.
- 2 September 2024
- Published by Instituto Mexicano del Seguro Social in Boletín Médico del Hospital Infantil de México
- Vol. 81 (4) , 253-254
Intravenous fluids in dehydrated children with acute gastroenteritis: evidence is needed
- 2 September 2024
- Published by Instituto Mexicano del Seguro Social in Boletín Médico del Hospital Infantil de México
- Vol. 81 (4) , 253-254
Intravenous fluids in dehydrated children with acute gastroenteritis: evidence is needed